NCT02183246View on ClinicalTrials.gov

Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

December 31, 2000

Conditions
Head and Neck Neoplasms
Interventions
DRUG

Porfiromycin

DRUG

Placebo

RADIATION

Radiotherapy

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY